Skip to content
← Index board

Health Optimization Index

High-Dose Melatonin

Nick’s assessment
Promising
Research evidence
C, mixed evidence
Attention
8.9 / 100▲ Rising this week
6.7/ 10

BioHarmony score

High-dose melatonin is most interesting for antioxidant and oncology-adjacent contexts, with Seely 2012 pooling 21 RCTs in adjuvant cancer care. The practical limit is uncertainty above typical sleep doses, especially long-term endocrine and next-day effects.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

High-dose melatonin is worth trying for advanced users with a clear reason, a conservative dose plan, and real monitoring for sedation, glucose, blood pressure, mood, and endocrine changes. It is not a casual sleep upgrade. The 6.5–7.0/10 score reflects a very broad multi-system footprint, moderate clinical evidence, strong independent mechanism support, and a safety profile that looks reassuring short term but under-studied long term above 50 mg.

✅ Best for: Experienced self-quantifiers exploring mitochondrial or antioxidant protocols, patients discussing oncology supportive care with their clinician, users testing short pulse dosing rather than nightly escalation, and people who can track sleep, glucose, blood pressure, and next-day performance. It is most defensible when the goal is oxidative-stress resilience rather than simply stronger sedation.

❌ Avoid if: You are pregnant, breastfeeding, in active fertility treatment, or living with bipolar disorder, unstable depression, uncontrolled diabetes, or low blood pressure. Be cautious with complex polypharmacy, anticoagulants, or fluvoxamine, and skip it if your mornings demand sharp alertness or if you are unwilling to stop when grogginess, nightmares, or glucose changes appear.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on High-Dose Melatonin
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.